塞拉万斯生物制药 TBPH
$0.00 +$0.00 (0.00%)
休市 · Oct 24, 12:40 am ET
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值$884.18M
市盈率（TTM）16.4
股息率–
TBPH 相关新闻
匹配 Theravance Biopharma(Delisted) 或代码 TBPH 的头条新闻，按最新排序。
- Theravance Biopharma(Delisted): Theravance Biopharma, Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: TBPH
- Theravance Biopharma(Delisted): Theravance Biopharma, Inc.- Broker-To-Broker Settlement/Exercise Considerations Option Symbol: TBPH
- Theravance Biopharma: Theravance Biopharma, Inc. - Anticipated Cash Settlement Option Symbol: TBPH
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Fractyl Health, Inc. (GUTS) and Theravance Biopharma (TBPH)
- H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Maintains Target Price $17
- H.C. Wainwright Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Raises Target Price to $17 中性
- Theravance Biopharma(TBPH.US) 10% Shareholder Sells US$5.79 Million in Common Stock
- BTIG Downgrades Theravance Biopharma(TBPH.US) to Hold Rating 负面
- Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Theravance Biopharma (TBPH)
- BTIG Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $21
- JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Raises Target Price to $19 正面
- B. Riley Securities Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Raises Target Price to $17 正面
- Oppenheimer Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Cuts Target Price to $13.67 负面
- JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Cuts Target Price to $17 负面
- H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Cuts Target Price to $15 负面
暂无评论——快来第一个聊聊 TBPH。
登录后参与讨论。